Infogene has a framework of highly qualified technical personnel in genetics, molecular virology and oncology (1 PhD in molecular genetics,1 PhD in molecular virology, 2 masters in biochemistry and 1 master in genetics and health biotechnology), with about 15 years of experience in the field of cancer. Infogene is currently one of the most competent laboratories, at national and international level, to perform molecular assays for detection and typing of human papillomavirus (HPV), the causative agent of cervical cancer.
Along with the know-how and competence, our laboratory is equipped with the latest instrumentation for molecular diagnostics, such as Polymerase Chain Reaction (PCR), Quantitative real-time PCR (qPCR), DNA-arrays and DNA sequencing platforms.
Infogene regularly participates in external quality control programs (EHEQAS , UKNEQAS) . With regard to detection / genotyping of HPV, the results obtained by our laboratory were excellent. Infogene meets the ISO 9001 requirements for the following activities: i) research and development in the early detection of cancer, ii) Distribution of MDs and iii) services for the early detection of cancer through molecular biology.